Zobrazeno 1 - 10
of 96
pro vyhledávání: '"W. Stenzinger"'
Autor:
W. Stenzinger, J.C.W. van de Loo
Publikováno v:
Fibrinolysis. 9:58-65
Summary This is a comprehensive description of the state of the art in preventing occurrence and progress of thrombotic and thromboembolic diseases. Anticoagulation with different heparin preparations and with oral anticoagulants as well as antiplate
Treatment of refractory multiple myeloma with the vincristine-adriamycin-dexamethasone (VAD) regimen
Publikováno v:
Blut. 61:55-59
Seventeen patients with advanced refractory multiple myeloma were treated with a 4-day continuous infusion of vincristine and adriamycin in combination with 4-day intermittent high-dose dexamethasone (VAD). Ten patients entered a partial remission (5
Autor:
W. Stenzinger, J. van de Loo
Publikováno v:
Hämostaseologie ISBN: 9783662076743
Orale Antikoagulanzien sind synthetisch hergestellte Derivate des naturlichen Dicoumarol (4-Hydroxycumarin). Sie zahlen zu den gebrauchlichsten Medikamenten in der antithrombotischen Therapie. Wirkungsprinzip und Pharmakokinetik dieser Substanzen sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8021f8e2900ee8966c008889fec3d358
https://doi.org/10.1007/978-3-662-07673-6_92
https://doi.org/10.1007/978-3-662-07673-6_92
Publikováno v:
Aktuelle Urologie. 21:353-355
Autor:
M. Gramatzki, J.T. Fischer, I.-M. von Broen, R. Henke, J. Oertel, E. Schäfer, J. Selbach, R. Coldewey, H. Wagner, R. Hein, H. J. Braun, Deicher H, D. Peest, M. Planker, C. Tirier, R. Leo, H. Bartels, W. Stenzinger, C.R. Meier, E. Schumacher, L. Hoffmann, M. Stennes, K. Schumacher, E. D. Kreuser, W. D. Maier, J. Wysk, R. Bartl, H. J. Weh, H.M. Reinhold
Publikováno v:
Oncology Research and Treatment. 13:458-460
277 untreated multiple myeloma patients of stage I (n = 33), II (n = 106) and III (n = 138) entered the study. Patients of stage II presenting a progressive tumor (n = 64) initially or during observat
Autor:
W, Stenzinger
Publikováno v:
Zeitschrift fur Kardiologie. 87
In recent years randomized clinical trials using standardized prothrombin time (international normalized ratio, INR) for the control of oral anticoagulant therapy have demonstrated that the use of a less intense therapeutic range decreases the rate o
Autor:
W, Stenzinger
Publikováno v:
Der Internist. 36(9)
Publikováno v:
British journal of urology. 75(3)
Autor:
B. Göbel, H. Bartels, K. Schumacher, M. Petit, W. Stenzinger, W. D. Maier, L. Hoffmann, P. Harms, C. Platzeck, J. Wysk, M. Planker, R. Leo, R. Bartl, H. Wagner, P. Von Wussow, R. Coldewey, W. Fett, D. Peest, E. D. Kreuser, J.T. Fischer, R. Henke, J. Oertel, Carl Richard Meier, M. Respondek, M. Stennes, C. Tirier, E. Schäfer, H. J. Braun, H. J. Weh, H. Deicher
Publikováno v:
European journal of cancer (Oxford, England : 1990). (2)
406 untreated multiple myeloma patients of stage I (n = 54), II (n = 148) and III (n = 204) were enrolled in the trial. 51/54 stage I and 60/148 stage II patients were asymptomatic and followed without treatment until disease progression (progression
Autor:
R M, Mesters, W, Stenzinger
Publikováno v:
Der Internist. 36(1)